BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 17553304)

  • 1. [Folate-poly-L-lysine-Gd-DTPA as MR contrast agent for tumor imaging via folate receptor-targeted delivery].
    Yuan Z; Liu SY; Xiao XS; Zhong GR; Jiang QJ
    Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):673-8. PubMed ID: 17553304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted magnetic resonance imaging with intraperitoneal and intravenous streptavidin (SA)-DTPA-Gd: a comparative study in tumor-bearing nude mice.
    Ye J; Xu YK; Liu X; Lü GS
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Feb; 26(2):139-43. PubMed ID: 16503514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MR characterization of mild hyperthermia-induced gadodiamide release from thermosensitive liposomes in solid tumors.
    Peller M; Schwerdt A; Hossann M; Reinl HM; Wang T; Sourbron S; Ogris M; Lindner LH
    Invest Radiol; 2008 Dec; 43(12):877-92. PubMed ID: 19002060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation using an HER-2/neu transgenic mouse model of a newly developed MR contrast agent with the effect of an antitumor drug.
    Sonoda A; Nitta N; Ohta S; Nitta-Seko A; Murata S; Jo J; Tabata Y; Takahashi M; Tani T; Murata K
    J Magn Reson Imaging; 2009 Oct; 30(4):907-10. PubMed ID: 19787744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Gd [DTPA-bis (2-aminoethoxy) ethane] polymeric contrast agent with gadodiamide injection for interstitial MR lymphography: experimental study with rabbits.
    Zhou Z; Guo J; Yu H; Zhu B; Liu C; Jiang X; Zhang M; Chen J
    J Magn Reson Imaging; 2005 Sep; 22(3):361-7. PubMed ID: 16106365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular imaging by a polyarginine derived cell penetrating peptide labeled magnetic resonance contrast agent, diethylenetriamine pentaacetic acid gadolinium.
    Guo YM; Liu M; Yang JL; Guo XJ; Wang SC; Duan XY; Wang P
    Chin Med J (Engl); 2007 Jan; 120(1):50-5. PubMed ID: 17254488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of Gd-BOPTA and Gd-DTPA in contrast-enhanced MR imaging of the liver].
    Zhang HM; Ouyang H; Zhou CW
    Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):111-5. PubMed ID: 16750014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorophyll-a analogues conjugated with aminobenzyl-DTPA as potential bifunctional agents for magnetic resonance imaging and photodynamic therapy.
    Li G; Slansky A; Dobhal MP; Goswami LN; Graham A; Chen Y; Kanter P; Alberico RA; Spernyak J; Morgan J; Mazurchuk R; Oseroff A; Grossman Z; Pandey RK
    Bioconjug Chem; 2005; 16(1):32-42. PubMed ID: 15656573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of [Gd(Bz-TTDA)]2- as a potential contrast agent in MR imaging of the hepatobiliary system: an animal study.
    Hsu JS; Jaw TS; Liu GC; Wang YM; Chen SH; Kuo YT; Jao JC; Li CW; Tsai KB
    J Magn Reson Imaging; 2004 Oct; 20(4):632-9. PubMed ID: 15390149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
    Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
    NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate receptor-mediated targeted polymeric gadolinium complexes for magnetic resonance imaging in pulmonary tumor xenografts.
    Yuan Z; Li WT; Ye XD; Liu SY; Xiao XS
    Exp Ther Med; 2012 May; 3(5):903-907. PubMed ID: 22969991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MR molecular imaging of early endothelial activation in focal ischemia.
    Barber PA; Foniok T; Kirk D; Buchan AM; Laurent S; Boutry S; Muller RN; Hoyte L; Tomanek B; Tuor UI
    Ann Neurol; 2004 Jul; 56(1):116-20. PubMed ID: 15236408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Gadolinium-loaded nanoparticle as a novel molecular imaging contrast agent for magnetic resonance imaging].
    Liu LZ; Guo GJ; Zeng MS; Lü YC; Liu XW; Cui CY; Wu PH; Li L
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):240-3. PubMed ID: 17425867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of biotin-avidin system in targeted magnetic resonance imaging].
    Liu X; Xu YK; Ye J
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1130-2. PubMed ID: 15485783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human comparative study of zinc and copper excretion via urine after administration of magnetic resonance imaging contrast agents.
    Kimura J; Ishiguchi T; Matsuda J; Ohno R; Nakamura A; Kamei S; Ohno K; Kawamura T; Murata K
    Radiat Med; 2005 Aug; 23(5):322-6. PubMed ID: 16342903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of renal function in normal and hydronephrotic kidneys in rats using gadolinium diethylenetetramine-pentaacetic acid enhanced dynamic magnetic resonance imaging.
    Wen JG; Chen Y; Ringgaard S; Frøkiaer J; Jørgensen TM; Stødkilde-Jørgensen H; Djurhuus JC
    J Urol; 2000 Apr; 163(4):1264-70. PubMed ID: 10737526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) for differential diagnosis of nonalcoholic steatohepatitis and fatty liver in rats using magnetic resonance imaging.
    Tsuda N; Okada M; Murakami T
    Invest Radiol; 2007 Apr; 42(4):242-7. PubMed ID: 17351431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A comparison between an ionic paramagnetic contrast agent (Gd-DTPA) and a nonionic one (Gd-DTPA-BMA) in functional kidney evaluation with magnetic resonance].
    Shariat Razavi I; Piovesana F; Stacul F; Cova M; Artero M; Carraro M; Pozzi Mucelli R; Dalla Palma L
    Radiol Med; 1997 Sep; 94(3):208-13. PubMed ID: 9446127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of CH3-DTPA-Gd (NMS60) as a new MR contrast agent: early phase II study in brain tumors and dual dynamic contrast-enhanced imaging.
    Ito M; Ogino H; Oshima H; Shiraki N; Shibamoto Y; Kasai H; Mase M; Kawamura Y; Miyati T
    Magn Reson Imaging; 2006 Jun; 24(5):625-30. PubMed ID: 16735185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.